The 2017-2018 seasonal influenza epidemics are severe in the US and Australia where A (H3N2) virus subtype dominated. Although circulating A (H3N2) virus antigen is not different from that recommended by the WHO for vaccine production, the overall interim estimate of vaccine effectiveness was under the historical average (33%) for A (H3N2) virus. The majority (USA) or all (Australia) dose of vaccine contains several amino acid changes in the hemagglutinin protein, which is produced from the necessary adaptation of the virus to embryonated chicken eggs used to manufacture the vaccine most. Previous reports have suggested the potential negative impact of the substitution of egg-driven performance of the vaccine. With the support of Barda, two vaccines licensed in the US is produced in cell culture: a recombinant influenza vaccine (RIV, Flublok ™) produced in insect cells and inactivated vaccines adult mammalian cells (ccIIV, Flucelvax ™). CcIIV quadrivalent (ccIIV4) vaccine for the 2017-2018 influenza season was produced using seed virus A (H3N2) distributed exclusively in cell culture and therefore less adaptative changes eggs. ccIIV dose fairly distributed (but not RIV dose) to allow the initial estimates of higher efficacy relative to traditional egg-based vaccine, the study details pending. The increased availability of certain product comparison vaccine effectiveness estimates for cell-based vaccine and egg-based can provide important clues to inform vaccine product improvements moving forward.
Diclofenac Diethylamine |
B1928-50 |
ApexBio |
50 mg |
EUR 153.6 |
Description: Diclofenac diethylamine is a nonsteroidal anti-inflammatory drug taken to reduce inflammation and as an analgesic reducing pain in certain conditions. |
Diclofenac Diethylamine |
B1928-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Diclofenac diethylamine is a nonsteroidal anti-inflammatory drug taken to reduce inflammation and as an analgesic reducing pain in certain conditions. |
2‐AMINO ACETAMIDE HYDROCHLORIDE (GLYCINAMIDE HYDROCHLORIDE) |
101003 |
Survival Technologies |
each |
Ask for price |
Acriflavine Hydrochloride |
A019-10G |
TOKU-E |
10 g |
EUR 66 |
Acriflavine Hydrochloride |
A019-25G |
TOKU-E |
25 g |
EUR 94.8 |
Amodiaquine hydrochloride |
A085-5G |
TOKU-E |
5 g |
EUR 66 |
Amastatin . hydrochloride |
10-016 |
ProSci |
5 mg |
EUR 440.88 |
Description: Slow, tight binding and competitive aminopeptidase (AP) inhibitor. Inhibits cytosolic leucine aminopeptidase, microsomal aminopeptidase M and bacterial leucine aminopeptidase, human serum aminopeptidase A (AP-A), aminopeptidase N (AP-N), tyrosine aminopeptidase, but not aminopeptidase B (AP-B). Amastatin is without effect on trypsin, papain, chymotrypsin, elastase, pepsin or thermolysin. Inhibits completely the Suc-Ala-Ala-Pro-Leu-pNA amidolytic enzyme. Slightly inhibits the formation of angiotensin III (Ang III) from Angiotensin II through AP-A, but significantly increases the potency of angiotensin III and [des-Asp1]-angiotensin I. Moderate inhibitor of mitochondrial intermediate peptidase (MIP). Weak inhibitor of simian immunodeficiency virus protease (SIV-PR). ANPEP (aminopeptidase N) is a host receptor targeted by porcine epidemic diarrhoea virus, human coronavirus 229E, feline coronavirus, canine coronavirus, transmissible gastroenteritis virus and infectious bronchitis virus. These viruses all belong to coronaviridae. ANPEP is therefore investigated as a potential target for SARS-CoV-2 infections. |
Tetracycline Hydrochloride |
A2517-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Description: antibiotictoxicstore at -20°C, warm to room temperature before usesoluble in water at 10mg/mlsoluble in ethanol at 5mg/ml |
Tetracycline Hydrochloride |
A2517-50 |
ApexBio |
50 mg |
EUR 157.2 |
Description: antibiotictoxicstore at -20°C, warm to room temperature before usesoluble in water at 10mg/mlsoluble in ethanol at 5mg/ml |
Alosetron Hydrochloride |
A3159-10 |
ApexBio |
10 mg |
EUR 129.6 |
Description: Alosetron is s Serotonin 5HT3-receptor antagonist that is used in treatment of irritable bowel syndrome. |
Alosetron Hydrochloride |
A3159-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Description: Alosetron is s Serotonin 5HT3-receptor antagonist that is used in treatment of irritable bowel syndrome. |
Alosetron Hydrochloride |
A3159-50 |
ApexBio |
50 mg |
EUR 268.8 |
Description: Alosetron is s Serotonin 5HT3-receptor antagonist that is used in treatment of irritable bowel syndrome. |
Asenapine hydrochloride |
A3192-10 |
ApexBio |
10 mg |
EUR 166.8 |
Description: Asenapine is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine shows high affinity (pKi) for numerous receptors. |
Asenapine hydrochloride |
A3192-100 |
ApexBio |
100 mg |
EUR 514.8 |
Description: Asenapine is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine shows high affinity (pKi) for numerous receptors. |
Asenapine hydrochloride |
A3192-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 180 |
Description: Asenapine is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine shows high affinity (pKi) for numerous receptors. |
Asenapine hydrochloride |
A3192-50 |
ApexBio |
50 mg |
EUR 320.4 |
Description: Asenapine is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine shows high affinity (pKi) for numerous receptors. |
AT7519 Hydrochloride |
A3197-10 |
ApexBio |
10 mg |
EUR 223.2 |
Description: IC50: AT7519 showed potent antiproliferative activity (40-940 nmol/L) in a panel of human tumor cell lines.Cyclin-dependent kinases (CDK) play a central role in the growth, division, and death of eukaryotic cell. |
AT7519 Hydrochloride |
A3197-100 |
ApexBio |
100 mg |
EUR 512.4 |
Description: IC50: AT7519 showed potent antiproliferative activity (40-940 nmol/L) in a panel of human tumor cell lines.Cyclin-dependent kinases (CDK) play a central role in the growth, division, and death of eukaryotic cell. |
AT7519 Hydrochloride |
A3197-5 |
ApexBio |
5 mg |
EUR 166.8 |
Description: IC50: AT7519 showed potent antiproliferative activity (40-940 nmol/L) in a panel of human tumor cell lines.Cyclin-dependent kinases (CDK) play a central role in the growth, division, and death of eukaryotic cell. |
AT7519 Hydrochloride |
A3197-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 180 |
Description: IC50: AT7519 showed potent antiproliferative activity (40-940 nmol/L) in a panel of human tumor cell lines.Cyclin-dependent kinases (CDK) play a central role in the growth, division, and death of eukaryotic cell. |
AT7519 Hydrochloride |
A3197-50 |
ApexBio |
50 mg |
EUR 404.4 |
Description: IC50: AT7519 showed potent antiproliferative activity (40-940 nmol/L) in a panel of human tumor cell lines.Cyclin-dependent kinases (CDK) play a central role in the growth, division, and death of eukaryotic cell. |
Atrasentan hydrochloride |
A3201-10 |
ApexBio |
10 mg |
EUR 710.4 |
Description: Description:IC50 Value: 0.0551 nM (for ET A receptor) [1]Atrasentan (A-147627) is an endothelin receptor antagonist being developed at Abbott Laboratories for the treatment of prostate cancer. |
Atrasentan hydrochloride |
A3201-5 |
ApexBio |
5 mg |
EUR 451.2 |
Description: Description:IC50 Value: 0.0551 nM (for ET A receptor) [1]Atrasentan (A-147627) is an endothelin receptor antagonist being developed at Abbott Laboratories for the treatment of prostate cancer. |
Atrasentan hydrochloride |
A3201-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 529.2 |
Description: Description:IC50 Value: 0.0551 nM (for ET A receptor) [1]Atrasentan (A-147627) is an endothelin receptor antagonist being developed at Abbott Laboratories for the treatment of prostate cancer. |
Atrasentan hydrochloride |
A3201-50 |
ApexBio |
50 mg |
EUR 2025.6 |
Description: Description:IC50 Value: 0.0551 nM (for ET A receptor) [1]Atrasentan (A-147627) is an endothelin receptor antagonist being developed at Abbott Laboratories for the treatment of prostate cancer. |
BMS345541 hydrochloride |
A3248-10 |
ApexBio |
10 mg |
EUR 282 |
Description: BMS-345541 is a highly selective inhibitor of IKK-1 and IKK-2 with IC50 values of 4?M and 0.3?M, respectively [1].BMS-345541 is a highly selective inhibitor of IKK that inhibits NF-?B-dependent transcription of pro-inflammatory cytokines both in vitro and in vivo. |
BMS345541 hydrochloride |
A3248-5 |
ApexBio |
5 mg |
EUR 205.2 |
Description: BMS-345541 is a highly selective inhibitor of IKK-1 and IKK-2 with IC50 values of 4?M and 0.3?M, respectively [1].BMS-345541 is a highly selective inhibitor of IKK that inhibits NF-?B-dependent transcription of pro-inflammatory cytokines both in vitro and in vivo. |
BMS345541 hydrochloride |
A3248-50 |
ApexBio |
50 mg |
EUR 714 |
Description: BMS-345541 is a highly selective inhibitor of IKK-1 and IKK-2 with IC50 values of 4?M and 0.3?M, respectively [1].BMS-345541 is a highly selective inhibitor of IKK that inhibits NF-?B-dependent transcription of pro-inflammatory cytokines both in vitro and in vivo. |
CCT241533 hydrochloride |
A3292-1 |
ApexBio |
1 mg |
EUR 147.6 |
Description: CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Inhibitors of CHK2 may increase the efficacy of genotoxic cancer therapies. CCT241533 has been identified and characterized as a novel CHK2 kinase inhibitor. |
CCT241533 hydrochloride |
A3292-10 |
ApexBio |
10 mg |
EUR 528 |
Description: CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Inhibitors of CHK2 may increase the efficacy of genotoxic cancer therapies. CCT241533 has been identified and characterized as a novel CHK2 kinase inhibitor. |
CCT241533 hydrochloride |
A3292-5 |
ApexBio |
5 mg |
EUR 386.4 |
Description: CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Inhibitors of CHK2 may increase the efficacy of genotoxic cancer therapies. CCT241533 has been identified and characterized as a novel CHK2 kinase inhibitor. |
Clemizole hydrochloride |
A3316-10 |
ApexBio |
10 mg |
EUR 170.4 |
Description: IC50: 8 mM (NS4B) The NS4B protein is a key player in HCV replication. Disrupting NS4B function thus represents an attractive new anti-HCV strategy. |
Clemizole hydrochloride |
A3316-100 |
ApexBio |
100 mg |
EUR 727.2 |
Description: IC50: 8 mM (NS4B) The NS4B protein is a key player in HCV replication. Disrupting NS4B function thus represents an attractive new anti-HCV strategy. |
Clemizole hydrochloride |
A3316-5 |
ApexBio |
5 mg |
EUR 129.6 |
Description: IC50: 8 mM (NS4B) The NS4B protein is a key player in HCV replication. Disrupting NS4B function thus represents an attractive new anti-HCV strategy. |
Clemizole hydrochloride |
A3316-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 142.8 |
Description: IC50: 8 mM (NS4B) The NS4B protein is a key player in HCV replication. Disrupting NS4B function thus represents an attractive new anti-HCV strategy. |
Clemizole hydrochloride |
A3316-50 |
ApexBio |
50 mg |
EUR 477.6 |
Description: IC50: 8 mM (NS4B) The NS4B protein is a key player in HCV replication. Disrupting NS4B function thus represents an attractive new anti-HCV strategy. |
Elacridar hydrochloride |
A3385-10 |
ApexBio |
10 mg |
EUR 224.4 |
Description: Elacridar is an inhibitor of breast cancer resistance protein (BCRP) and P-glycoprotein (P-GP) that has been used to improve the brain distribution of drugs. Recent studies have revealed that elacridar could probably be the substrate of these multidrug transporters (MDTs) [2]. |
Elacridar hydrochloride |
A3385-100 |
ApexBio |
100 mg |
EUR 1015.2 |
Description: Elacridar is an inhibitor of breast cancer resistance protein (BCRP) and P-glycoprotein (P-GP) that has been used to improve the brain distribution of drugs. Recent studies have revealed that elacridar could probably be the substrate of these multidrug transporters (MDTs) [2]. |
Elacridar hydrochloride |
A3385-50 |
ApexBio |
50 mg |
EUR 598.8 |
Description: Elacridar is an inhibitor of breast cancer resistance protein (BCRP) and P-glycoprotein (P-GP) that has been used to improve the brain distribution of drugs. Recent studies have revealed that elacridar could probably be the substrate of these multidrug transporters (MDTs) [2]. |
Etifoxine hydrochloride |
A3401-10 |
ApexBio |
10 mg |
EUR 180 |
Description: Etifoxine is potentiator of GABAA receptor function in cultured neurons. Etifoxine preferentially acts on ?2 or ?3 subunit-containing GABAA receptors. Etifoxine exhibits anxiolytic activity in rodents and humans with no sedative, myorelaxant or mnesic side effects. |
Etifoxine hydrochloride |
A3401-50 |
ApexBio |
50 mg |
EUR 536.4 |
Description: Etifoxine is potentiator of GABAA receptor function in cultured neurons. Etifoxine preferentially acts on ?2 or ?3 subunit-containing GABAA receptors. Etifoxine exhibits anxiolytic activity in rodents and humans with no sedative, myorelaxant or mnesic side effects. |
Gefitinib hydrochloride |
A3433-100 |
ApexBio |
100 mg |
EUR 205.2 |
Description: The EGFR is a Mr 170,000 transmembrane glycoprotein with an external binding domain and an intracellular tyrosine kinase domain. Gefitinib (ZD-1839, Iressa) is an Epidermal Growth Factor Receptor-selective Tyrosine Kinase Inhibitor. |
Gefitinib hydrochloride |
A3433-250 |
ApexBio |
250 mg |
EUR 324 |
Description: The EGFR is a Mr 170,000 transmembrane glycoprotein with an external binding domain and an intracellular tyrosine kinase domain. Gefitinib (ZD-1839, Iressa) is an Epidermal Growth Factor Receptor-selective Tyrosine Kinase Inhibitor. |
Guanfacine hydrochloride |
A3451-10 |
ApexBio |
10 mg |
EUR 130.8 |
Description: Guanfacine, an anti-hypertensive agent, is a selective agonist of ?2A-adrenoceptor (?2AR) with a Kd value of 31 nM, displaying 60-fold selectivity over ?2B-adrenoceptors. |
Guanfacine hydrochloride |
A3451-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Description: Guanfacine, an anti-hypertensive agent, is a selective agonist of ?2A-adrenoceptor (?2AR) with a Kd value of 31 nM, displaying 60-fold selectivity over ?2B-adrenoceptors. |
Guanfacine hydrochloride |
A3451-50 |
ApexBio |
50 mg |
EUR 315.6 |
Description: Guanfacine, an anti-hypertensive agent, is a selective agonist of ?2A-adrenoceptor (?2AR) with a Kd value of 31 nM, displaying 60-fold selectivity over ?2B-adrenoceptors. |
Hydroxyfasudil hydrochloride |
A3479-10 |
ApexBio |
10 mg |
EUR 271.2 |
Description: Description:IC50 Value: 0.12 uM (ROCK1); 0.17 uM (ROCK2) [1]Hydroxyfasudil, metabolite of Fasudil, is a potent Rho-kinase inhibitor and vasodilator. |
Hydroxyfasudil hydrochloride |
A3479-50 |
ApexBio |
50 mg |
EUR 703.2 |
Description: Description:IC50 Value: 0.12 uM (ROCK1); 0.17 uM (ROCK2) [1]Hydroxyfasudil, metabolite of Fasudil, is a potent Rho-kinase inhibitor and vasodilator. |
Icotinib Hydrochloride |
A3482-10 |
ApexBio |
10 mg |
EUR 240 |
Description: Icotinib Hydrochloride is a potent and highly selective inhibitor of epidermal growth factor receptor tyrosine kinases (EGFR-TKI) with IC50 value of 5 nM. |
Icotinib Hydrochloride |
A3482-5 |
ApexBio |
5 mg |
EUR 186 |
Description: Icotinib Hydrochloride is a potent and highly selective inhibitor of epidermal growth factor receptor tyrosine kinases (EGFR-TKI) with IC50 value of 5 nM. |
Icotinib Hydrochloride |
A3482-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 199.2 |
Description: Icotinib Hydrochloride is a potent and highly selective inhibitor of epidermal growth factor receptor tyrosine kinases (EGFR-TKI) with IC50 value of 5 nM. |
Icotinib Hydrochloride |
A3482-50 |
ApexBio |
50 mg |
EUR 584.4 |
Description: Icotinib Hydrochloride is a potent and highly selective inhibitor of epidermal growth factor receptor tyrosine kinases (EGFR-TKI) with IC50 value of 5 nM. |
Imatinib hydrochloride |
A3487-100 |
ApexBio |
100 mg |
EUR 157.2 |
Description: Description:IC50 Value: 100 nM (PDGFR) [1]; 100 nM (c-Kit) [2]Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 ?M, 0.1 ?M and 0.1 ?M, respectively. |
Istaroxime hydrochloride |
A3508-10 |
ApexBio |
10 mg |
EUR 564 |
Description: Istaroxime hydrochloride(PST2744) is a novel inhibitor of Na+/K+-ATPase with IC50 value of 0.43±0.15?M [1]. |
Istaroxime hydrochloride |
A3508-100 |
ApexBio |
100 mg |
EUR 2203.2 |
Description: Istaroxime hydrochloride(PST2744) is a novel inhibitor of Na+/K+-ATPase with IC50 value of 0.43±0.15?M [1]. |
Istaroxime hydrochloride |
A3508-2 |
ApexBio |
2 mg |
EUR 278.4 |
Description: Istaroxime hydrochloride(PST2744) is a novel inhibitor of Na+/K+-ATPase with IC50 value of 0.43±0.15?M [1]. |
Istaroxime hydrochloride |
A3508-5 |
ApexBio |
5 mg |
EUR 390 |
Description: Istaroxime hydrochloride(PST2744) is a novel inhibitor of Na+/K+-ATPase with IC50 value of 0.43±0.15?M [1]. |
Istaroxime hydrochloride |
A3508-50 |
ApexBio |
50 mg |
EUR 1476 |
Description: Istaroxime hydrochloride(PST2744) is a novel inhibitor of Na+/K+-ATPase with IC50 value of 0.43±0.15?M [1]. |
PJ34 hydrochloride |
A4159-10 |
ApexBio |
10 mg |
EUR 142.8 |
Description: PJ34 is a novel and potent inhibitor of poly(ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair and cell proliferation, that dose-dependently inhibits purified PARP enzyme in a cell-free assay with half maximal effective concentration EC50 value of 20 nM. |
PJ34 hydrochloride |
A4159-5 |
ApexBio |
5 mg |
EUR 129.6 |
Description: PJ34 is a novel and potent inhibitor of poly(ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair and cell proliferation, that dose-dependently inhibits purified PARP enzyme in a cell-free assay with half maximal effective concentration EC50 value of 20 nM. |
PJ34 hydrochloride |
A4159-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 150 |
Description: PJ34 is a novel and potent inhibitor of poly(ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair and cell proliferation, that dose-dependently inhibits purified PARP enzyme in a cell-free assay with half maximal effective concentration EC50 value of 20 nM. |
PJ34 hydrochloride |
A4159-50 |
ApexBio |
50 mg |
EUR 296.4 |
Description: PJ34 is a novel and potent inhibitor of poly(ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair and cell proliferation, that dose-dependently inhibits purified PARP enzyme in a cell-free assay with half maximal effective concentration EC50 value of 20 nM. |
PJ34 hydrochloride |
A4159-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: PJ34 is a novel and potent inhibitor of poly(ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair and cell proliferation, that dose-dependently inhibits purified PARP enzyme in a cell-free assay with half maximal effective concentration EC50 value of 20 nM. |
RETRA hydrochloride |
A4485-10 |
ApexBio |
10 mg |
EUR 369.6 |
Description: IC50: Inhibit tumor cells growth with an IC50of about 4 M.Being defective for the tumor-suppressor function, mutant p53, a major contributor to malignancy, exerts oncogenic activity also by blocking another tumor-suppressing protein - p73. |
RETRA hydrochloride |
A4485-50 |
ApexBio |
50 mg |
EUR 1363.2 |
Description: IC50: Inhibit tumor cells growth with an IC50of about 4 M.Being defective for the tumor-suppressor function, mutant p53, a major contributor to malignancy, exerts oncogenic activity also by blocking another tumor-suppressing protein - p73. |
Thiamine Hydrochloride |
20-abx082137 |
Abbexa |
|
|
|
Vancomycin hydrochloride |
20-abx082225 |
Abbexa |
|
|
|
Pyridoxine hydrochloride |
abx082298-25g |
Abbexa |
25 g |
EUR 260.4 |
|
Thiamine Hydrochloride |
20-abx082339 |
Abbexa |
|
|
|
Betaine Hydrochloride |
abx082532-100g |
Abbexa |
100 g |
EUR 243.6 |
|
Vancomycin hydrochloride |
20-abx082574 |
Abbexa |
|
|
|
Thiamine Hydrochloride |
abx082609-25kg |
Abbexa |
25 kg |
EUR 6307.2 |
|
Doxorubicin Hydrochloride |
20-abx076623 |
Abbexa |
|
|
|
Erlotinib Hydrochloride |
20-abx076664 |
Abbexa |
|
|
|
FTY720 Hydrochloride |
20-abx076665 |
Abbexa |
|
|
|
Terazosin Hydrochloride |
20-abx076677 |
Abbexa |
|
|
|
GSK690693 Hydrochloride |
20-abx076782 |
Abbexa |
|
|
|
Amiodarone Hydrochloride |
abx076829-1g |
Abbexa |
1 g |
EUR 326.4 |
|
Metformin Hydrochloride |
abx076830-5g |
Abbexa |
5 g |
EUR 276 |
|
Bestatin hydrochloride |
A8621-10 |
ApexBio |
10 mg |
EUR 157.2 |
Description: Bestatin hydrochloride, also known as Ubenimex, is an inhibitor of aminopeptidase B and N (APN)/CD13 [1].Bestatin, an antibiotic of microbial origin, is a potent inhibitor of some aminopeptidases which can be administered to cultured cells, intact animals and humans with low toxicity. |
Bestatin hydrochloride |
A8621-100 |
ApexBio |
100 mg |
EUR 532.8 |
Description: Bestatin hydrochloride, also known as Ubenimex, is an inhibitor of aminopeptidase B and N (APN)/CD13 [1].Bestatin, an antibiotic of microbial origin, is a potent inhibitor of some aminopeptidases which can be administered to cultured cells, intact animals and humans with low toxicity. |
Bestatin hydrochloride |
A8621-25 |
ApexBio |
25 mg |
EUR 226.8 |
Description: Bestatin hydrochloride, also known as Ubenimex, is an inhibitor of aminopeptidase B and N (APN)/CD13 [1].Bestatin, an antibiotic of microbial origin, is a potent inhibitor of some aminopeptidases which can be administered to cultured cells, intact animals and humans with low toxicity. |
Bestatin hydrochloride |
A8621-5 |
ApexBio |
5 mg |
EUR 129.6 |
Description: Bestatin hydrochloride, also known as Ubenimex, is an inhibitor of aminopeptidase B and N (APN)/CD13 [1].Bestatin, an antibiotic of microbial origin, is a potent inhibitor of some aminopeptidases which can be administered to cultured cells, intact animals and humans with low toxicity. |
Flavopiridol hydrochloride |
A8640-10 |
ApexBio |
10 mg |
EUR 129.6 |
Description: Flavopiridol hydrochloride is a selective inhibitor of CDK1, CDK2, CDK4 and CDK6 with IC50 value all ~41 nM as well as CDK7 with 300nM [1] [2] [3].CDKs are protein kinase families which involve in the process of regulating transcription, mRNA processing, cell differentiation and cell cycle. |
Flavopiridol hydrochloride |
A8640-100 |
ApexBio |
100 mg |
EUR 528 |
Description: Flavopiridol hydrochloride is a selective inhibitor of CDK1, CDK2, CDK4 and CDK6 with IC50 value all ~41 nM as well as CDK7 with 300nM [1] [2] [3].CDKs are protein kinase families which involve in the process of regulating transcription, mRNA processing, cell differentiation and cell cycle. |
Flavopiridol hydrochloride |
A8640-1000 |
ApexBio |
1 g |
EUR 3259.2 |
Description: Flavopiridol hydrochloride is a selective inhibitor of CDK1, CDK2, CDK4 and CDK6 with IC50 value all ~41 nM as well as CDK7 with 300nM [1] [2] [3].CDKs are protein kinase families which involve in the process of regulating transcription, mRNA processing, cell differentiation and cell cycle. |
Flavopiridol hydrochloride |
A8640-25 |
ApexBio |
25 mg |
EUR 199.2 |
Description: Flavopiridol hydrochloride is a selective inhibitor of CDK1, CDK2, CDK4 and CDK6 with IC50 value all ~41 nM as well as CDK7 with 300nM [1] [2] [3].CDKs are protein kinase families which involve in the process of regulating transcription, mRNA processing, cell differentiation and cell cycle. |
Flavopiridol hydrochloride |
A8640-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Description: Flavopiridol hydrochloride is a selective inhibitor of CDK1, CDK2, CDK4 and CDK6 with IC50 value all ~41 nM as well as CDK7 with 300nM [1] [2] [3].CDKs are protein kinase families which involve in the process of regulating transcription, mRNA processing, cell differentiation and cell cycle. |
Acriflavine Hydrochloride |
AB4433 |
Bio Basic |
25g |
EUR 79.84 |
|
PD153035 hydrochloride |
A8199-10 |
ApexBio |
10 mg |
EUR 141.6 |
Description: PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. |
PD153035 hydrochloride |
A8199-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 150 |
Description: PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. |
PD153035 hydrochloride |
A8199-50 |
ApexBio |
50 mg |
EUR 404.4 |
Description: PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. |
PD153035 hydrochloride |
A8199-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. |
Erlotinib Hydrochloride |
A8234-1000 |
ApexBio |
1 g |
EUR 129.6 |
Description: Erlotinib hydrochloride (the trade name Tarceva?) is a directly acting inhibitor of epidermal growth factor receptor (EGFR/HER-1) tyrosine kinase with an IC50 of 2 nM.Epidermal growth factor receptor (EGFR) is one member of the ErbB family which includes EGFR (ErbB1), ErbB2, ErbB3 and ErbB4. |
Erlotinib Hydrochloride |
A8234-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Erlotinib hydrochloride (the trade name Tarceva?) is a directly acting inhibitor of epidermal growth factor receptor (EGFR/HER-1) tyrosine kinase with an IC50 of 2 nM.Epidermal growth factor receptor (EGFR) is one member of the ErbB family which includes EGFR (ErbB1), ErbB2, ErbB3 and ErbB4. |
Erlotinib Hydrochloride |
A8234-5000 |
ApexBio |
5 g |
EUR 309.6 |
Description: Erlotinib hydrochloride (the trade name Tarceva?) is a directly acting inhibitor of epidermal growth factor receptor (EGFR/HER-1) tyrosine kinase with an IC50 of 2 nM.Epidermal growth factor receptor (EGFR) is one member of the ErbB family which includes EGFR (ErbB1), ErbB2, ErbB3 and ErbB4. |
Pazopanib Hydrochloride |
A8347-100 |
ApexBio |
100 mg |
EUR 268.8 |
Description: Pazopanib HCl is a receptor tyrosine kinase inhibitor that targets multiple kinases, including VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit, and c-Fms, with IC50s 10nM, 30nM, 47nM, 84nM, 74nM, 140nM, and 146nM respectively [1-3]. |
Pazopanib Hydrochloride |
A8347-25 |
ApexBio |
25 mg |
EUR 129.6 |
Description: Pazopanib HCl is a receptor tyrosine kinase inhibitor that targets multiple kinases, including VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit, and c-Fms, with IC50s 10nM, 30nM, 47nM, 84nM, 74nM, 140nM, and 146nM respectively [1-3]. |
Pazopanib Hydrochloride |
A8347-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Pazopanib HCl is a receptor tyrosine kinase inhibitor that targets multiple kinases, including VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit, and c-Fms, with IC50s 10nM, 30nM, 47nM, 84nM, 74nM, 140nM, and 146nM respectively [1-3]. |
Pazopanib Hydrochloride |
A8347-500 |
ApexBio |
500 mg |
EUR 727.2 |
Description: Pazopanib HCl is a receptor tyrosine kinase inhibitor that targets multiple kinases, including VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit, and c-Fms, with IC50s 10nM, 30nM, 47nM, 84nM, 74nM, 140nM, and 146nM respectively [1-3]. |
Pazopanib Hydrochloride |
A8347-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Pazopanib HCl is a receptor tyrosine kinase inhibitor that targets multiple kinases, including VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit, and c-Fms, with IC50s 10nM, 30nM, 47nM, 84nM, 74nM, 140nM, and 146nM respectively [1-3]. |
LDN193189 Hydrochloride |
A3545-10 |
ApexBio |
10 mg |
EUR 282 |
Description: LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor. It inhibits activin receptor-like kinase-2 (ALK2) and ALK3 with IC50 values of 5 nM and 30 nM, respectively [1]. |
LDN193189 Hydrochloride |
A3545-5 |
ApexBio |
5 mg |
EUR 177.6 |
Description: LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor. It inhibits activin receptor-like kinase-2 (ALK2) and ALK3 with IC50 values of 5 nM and 30 nM, respectively [1]. |
LDN193189 Hydrochloride |
A3545-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 268.8 |
Description: LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor. It inhibits activin receptor-like kinase-2 (ALK2) and ALK3 with IC50 values of 5 nM and 30 nM, respectively [1]. |
LDN193189 Hydrochloride |
A3545-50 |
ApexBio |
50 mg |
EUR 895.2 |
Description: LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor. It inhibits activin receptor-like kinase-2 (ALK2) and ALK3 with IC50 values of 5 nM and 30 nM, respectively [1]. |
LDN193189 Hydrochloride |
A3545-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor. It inhibits activin receptor-like kinase-2 (ALK2) and ALK3 with IC50 values of 5 nM and 30 nM, respectively [1]. |
Lenalidomide hydrochloride |
A3547-100 |
ApexBio |
100 mg |
EUR 226.8 |
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
Lenalidomide hydrochloride |
A3547-250 |
ApexBio |
250 mg |
EUR 268.8 |
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
Lenalidomide hydrochloride |
A3547-50 |
ApexBio |
50 mg |
EUR 184.8 |
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
Lenalidomide hydrochloride |
A3547-500 |
ApexBio |
500 mg |
EUR 309.6 |
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
Mefloquine hydrochloride |
A3593-100 |
ApexBio |
100 mg |
EUR 135.6 |
Description: Description:IC50 Value: 1 microM ( for K+ channel) [1]Mefloquine is a quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine. Mefloquine is widely used in both the treatment and prophylaxis of Plasmodium falciparum malaria. |
Mefloquine hydrochloride |
A3593-1000 |
ApexBio |
1 g |
EUR 456 |
Description: Description:IC50 Value: 1 microM ( for K+ channel) [1]Mefloquine is a quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine. Mefloquine is widely used in both the treatment and prophylaxis of Plasmodium falciparum malaria. |
Mefloquine hydrochloride |
A3593-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 142.8 |
Description: Description:IC50 Value: 1 microM ( for K+ channel) [1]Mefloquine is a quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine. Mefloquine is widely used in both the treatment and prophylaxis of Plasmodium falciparum malaria. |
MPEP Hydrochloride |
A3633-10 |
ApexBio |
10 mg |
EUR 142.8 |
Description: IC50: 36 nMMPEP is a potent, selective and systemically active mGlu5 receptor antagonist. Metabotropic glutamate (mGlu) receptors are a of G-protein-coupled receptor family linked to multiple second messengers and modulation of ion channel functions in the nervous system. |
MPEP Hydrochloride |
A3633-50 |
ApexBio |
50 mg |
EUR 379.2 |
Description: IC50: 36 nMMPEP is a potent, selective and systemically active mGlu5 receptor antagonist. Metabotropic glutamate (mGlu) receptors are a of G-protein-coupled receptor family linked to multiple second messengers and modulation of ion channel functions in the nervous system. |
MPTP hydrochloride |
A3634-10 |
ApexBio |
10 mg |
EUR 162 |
Description: IC50 Value: 53uM?inhibited the nerve-evoked twitches of phrenic nerve-hemidiaphragm preparations from ICR mice? . MPTP HCl (Sigma-Chem.) induced reduction in the DOPAC HVA/dopamine (DA) ratio and increase in striatal ascorbate (AS) oxidation in rats [1]. |
MPTP hydrochloride |
A3634-50 |
ApexBio |
50 mg |
EUR 344.4 |
Description: IC50 Value: 53uM?inhibited the nerve-evoked twitches of phrenic nerve-hemidiaphragm preparations from ICR mice? . MPTP HCl (Sigma-Chem.) induced reduction in the DOPAC HVA/dopamine (DA) ratio and increase in striatal ascorbate (AS) oxidation in rats [1]. |
MTEP hydrochloride |
A3636-10 |
ApexBio |
10 mg |
EUR 205.2 |
Description: IC50: 5 nMMTEP is a selective metabotropic glutamate receptor subtype 5 (mGluR5) antagonist.The mGluRs are classified into three groups: group I (mGluR1 and 5), group II (mGluR2 and 3) and group III (mGluR4, 6, 7 and 8). |
MTEP hydrochloride |
A3636-5 |
ApexBio |
5 mg |
EUR 153.6 |
Description: IC50: 5 nMMTEP is a selective metabotropic glutamate receptor subtype 5 (mGluR5) antagonist.The mGluRs are classified into three groups: group I (mGluR1 and 5), group II (mGluR2 and 3) and group III (mGluR4, 6, 7 and 8). |
MTEP hydrochloride |
A3636-50 |
ApexBio |
50 mg |
EUR 686.4 |
Description: IC50: 5 nMMTEP is a selective metabotropic glutamate receptor subtype 5 (mGluR5) antagonist.The mGluRs are classified into three groups: group I (mGluR1 and 5), group II (mGluR2 and 3) and group III (mGluR4, 6, 7 and 8). |
Olprinone Hydrochloride |
A3683-100 |
ApexBio |
100 mg |
EUR 408 |
Description: Olprinone is a selective phosphodiesterase 3 (PDE3) inhibitor. Olprinone is used as cardiotonic agent with positive inotropic and vasodilating effects. Olprinone has been reported to improve microcirculation and attenuate inflammation. |
Olprinone Hydrochloride |
A3683-25 |
ApexBio |
25 mg |
EUR 199.2 |
Description: Olprinone is a selective phosphodiesterase 3 (PDE3) inhibitor. Olprinone is used as cardiotonic agent with positive inotropic and vasodilating effects. Olprinone has been reported to improve microcirculation and attenuate inflammation. |
Olprinone Hydrochloride |
A3683-500 |
ApexBio |
500 mg |
EUR 1104 |
Description: Olprinone is a selective phosphodiesterase 3 (PDE3) inhibitor. Olprinone is used as cardiotonic agent with positive inotropic and vasodilating effects. Olprinone has been reported to improve microcirculation and attenuate inflammation. |
Pitolisant hydrochloride |
A3727-10 |
ApexBio |
10 mg |
EUR 201.6 |
Description: Pitolisant HCl (BF2.649; Ciproxidine) is a potent, novel, and selective nonimidazole inverse agonist at the recombinant human H3 receptor with a Ki value of 0.16 nM[1]. |
Pitolisant hydrochloride |
A3727-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Description: Pitolisant HCl (BF2.649; Ciproxidine) is a potent, novel, and selective nonimidazole inverse agonist at the recombinant human H3 receptor with a Ki value of 0.16 nM[1]. |
Pitolisant hydrochloride |
A3727-50 |
ApexBio |
50 mg |
EUR 682.8 |
Description: Pitolisant HCl (BF2.649; Ciproxidine) is a potent, novel, and selective nonimidazole inverse agonist at the recombinant human H3 receptor with a Ki value of 0.16 nM[1]. |
PRT062607 Hydrochloride |
A3736-25 |
ApexBio |
25 mg |
EUR 456 |
Description: PRT062607 Hydrochloride is a highly selective and novel SYK inhibitor with IC50 value of 1 nM. Spleen tyrosine kinase (SYK) is a cytoplasmic tyrosine kinase and primarily expressed in hematopoietic cells including B-cells. |
PRT062607 Hydrochloride |
A3736-5 |
ApexBio |
5 mg |
EUR 224.4 |
Description: PRT062607 Hydrochloride is a highly selective and novel SYK inhibitor with IC50 value of 1 nM. Spleen tyrosine kinase (SYK) is a cytoplasmic tyrosine kinase and primarily expressed in hematopoietic cells including B-cells. |
PRT062607 Hydrochloride |
A3736-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 240 |
Description: PRT062607 Hydrochloride is a highly selective and novel SYK inhibitor with IC50 value of 1 nM. Spleen tyrosine kinase (SYK) is a cytoplasmic tyrosine kinase and primarily expressed in hematopoietic cells including B-cells. |
PRT062607 Hydrochloride |
A3736-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: PRT062607 Hydrochloride is a highly selective and novel SYK inhibitor with IC50 value of 1 nM. Spleen tyrosine kinase (SYK) is a cytoplasmic tyrosine kinase and primarily expressed in hematopoietic cells including B-cells. |
Regorafenib hydrochloride |
A3750-10 |
ApexBio |
10 mg |
EUR 150 |
Description: Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. |
Regorafenib hydrochloride |
A3750-100 |
ApexBio |
100 mg |
EUR 282 |
Description: Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. |
Regorafenib hydrochloride |
A3750-200 |
ApexBio |
200 mg |
EUR 582 |
Description: Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. |
Regorafenib hydrochloride |
A3750-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 199.2 |
Description: Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. |
Regorafenib hydrochloride |
A3750-50 |
ApexBio |
50 mg |
EUR 199.2 |
Description: Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. |
Resminostat hydrochloride |
A3755-10 |
ApexBio |
10 mg |
EUR 428.4 |
Description: Resminostat is an inhibitor of histone deacetylase (HDAC) with IC50 values of 42.5nM, 50.1nM and 71.8nM, respectively against HDAC1, 3 and 6 [1]. |
Resminostat hydrochloride |
A3755-100 |
ApexBio |
100 mg |
EUR 1905.6 |
Description: Resminostat is an inhibitor of histone deacetylase (HDAC) with IC50 values of 42.5nM, 50.1nM and 71.8nM, respectively against HDAC1, 3 and 6 [1]. |
Resminostat hydrochloride |
A3755-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 464.4 |
Description: Resminostat is an inhibitor of histone deacetylase (HDAC) with IC50 values of 42.5nM, 50.1nM and 71.8nM, respectively against HDAC1, 3 and 6 [1]. |
Resminostat hydrochloride |
A3755-50 |
ApexBio |
50 mg |
EUR 1209.6 |
Description: Resminostat is an inhibitor of histone deacetylase (HDAC) with IC50 values of 42.5nM, 50.1nM and 71.8nM, respectively against HDAC1, 3 and 6 [1]. |
Rimonabant hydrochloride |
A3766-10 |
ApexBio |
10 mg |
EUR 186 |
Description: Rimonabant, also known as SR141716, was the first selective central cannabinoid (CB1) receptor inverse agonist (Ki = 1.8 nM) to be developed as an appetite suppressant, anti-obesity drug. |
Rimonabant hydrochloride |
A3766-100 |
ApexBio |
100 mg |
EUR 710.4 |
Description: Rimonabant, also known as SR141716, was the first selective central cannabinoid (CB1) receptor inverse agonist (Ki = 1.8 nM) to be developed as an appetite suppressant, anti-obesity drug. |
Rimonabant hydrochloride |
A3766-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 199.2 |
Description: Rimonabant, also known as SR141716, was the first selective central cannabinoid (CB1) receptor inverse agonist (Ki = 1.8 nM) to be developed as an appetite suppressant, anti-obesity drug. |
Rimonabant hydrochloride |
A3766-50 |
ApexBio |
50 mg |
EUR 494.4 |
Description: Rimonabant, also known as SR141716, was the first selective central cannabinoid (CB1) receptor inverse agonist (Ki = 1.8 nM) to be developed as an appetite suppressant, anti-obesity drug. |
Rotigotine hydrochloride |
A3777-100 |
ApexBio |
100 mg |
EUR 480 |
Description: Rotigotine is dopamine D2 and D3 receptor agonist. Ki values are 13 and 0.71 nM for D2 and D3 respectively. Rotigotine also has significant affinity for 5-HT1A and adrenergic ?2B receptors. Rotigotine exhibits antiparkinsonian acitivity. |
Rotigotine hydrochloride |
A3777-200 |
ApexBio |
200 mg |
EUR 812.4 |
Description: Rotigotine is dopamine D2 and D3 receptor agonist. Ki values are 13 and 0.71 nM for D2 and D3 respectively. Rotigotine also has significant affinity for 5-HT1A and adrenergic ?2B receptors. Rotigotine exhibits antiparkinsonian acitivity. |
Rotigotine hydrochloride |
A3777-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 417.6 |
Description: Rotigotine is dopamine D2 and D3 receptor agonist. Ki values are 13 and 0.71 nM for D2 and D3 respectively. Rotigotine also has significant affinity for 5-HT1A and adrenergic ?2B receptors. Rotigotine exhibits antiparkinsonian acitivity. |
Rotigotine hydrochloride |
A3777-50 |
ApexBio |
50 mg |
EUR 360 |
Description: Rotigotine is dopamine D2 and D3 receptor agonist. Ki values are 13 and 0.71 nM for D2 and D3 respectively. Rotigotine also has significant affinity for 5-HT1A and adrenergic ?2B receptors. Rotigotine exhibits antiparkinsonian acitivity. |
Rotigotine hydrochloride |
A3777-500 |
ApexBio |
500 mg |
EUR 1663.2 |
Description: Rotigotine is dopamine D2 and D3 receptor agonist. Ki values are 13 and 0.71 nM for D2 and D3 respectively. Rotigotine also has significant affinity for 5-HT1A and adrenergic ?2B receptors. Rotigotine exhibits antiparkinsonian acitivity. |
Tipiracil hydrochloride |
A3875-10 |
ApexBio |
10 mg |
EUR 553.2 |
Description: Tipiracil is an inhibitor of Thymidine phosphorylase (TP). Thymidine phosphorylase (TP)is a key enzyme in the pyrimidine nucleoside salvage pathway. |
Tipiracil hydrochloride |
A3875-25 |
ApexBio |
25 mg |
EUR 774 |
Description: Tipiracil is an inhibitor of Thymidine phosphorylase (TP). Thymidine phosphorylase (TP)is a key enzyme in the pyrimidine nucleoside salvage pathway. |
Tipiracil hydrochloride |
A3875-5 |
ApexBio |
5 mg |
EUR 382.8 |
Description: Tipiracil is an inhibitor of Thymidine phosphorylase (TP). Thymidine phosphorylase (TP)is a key enzyme in the pyrimidine nucleoside salvage pathway. |
Tipiracil hydrochloride |
A3875-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 351.6 |
Description: Tipiracil is an inhibitor of Thymidine phosphorylase (TP). Thymidine phosphorylase (TP)is a key enzyme in the pyrimidine nucleoside salvage pathway. |
Tipiracil hydrochloride |
A3875-50 |
ApexBio |
50 mg |
EUR 1230 |
Description: Tipiracil is an inhibitor of Thymidine phosphorylase (TP). Thymidine phosphorylase (TP)is a key enzyme in the pyrimidine nucleoside salvage pathway. |
Vandetanib hydrochloride |
A3906-100 |
ApexBio |
100 mg |
EUR 517.2 |
Description: Description: IC50 Value: 40 nM (VEGFR2) [1]; 500 nM (EGFR) [2] Vandetanib is an anti-cancer drug that is used for the treatment of certain tumours of thethyroid gland. |
Vandetanib hydrochloride |
A3906-25 |
ApexBio |
25 mg |
EUR 201.6 |
Description: Description: IC50 Value: 40 nM (VEGFR2) [1]; 500 nM (EGFR) [2] Vandetanib is an anti-cancer drug that is used for the treatment of certain tumours of thethyroid gland. |
Vernakalant Hydrochloride |
A3915-10 |
ApexBio |
10 mg |
EUR 847.2 |
Description: IC50: Vernakalant inhibits two specific potassium currents, IKur (IC50 = 9 ??) and IKACh (IC50=10 ?M) which are only present in atrial myocardium [1].Vernakalant blocks atrial potassium channels, thereby prolonging repolarization. |
Vernakalant Hydrochloride |
A3915-100 |
ApexBio |
100 mg |
EUR 3316.8 |
Description: IC50: Vernakalant inhibits two specific potassium currents, IKur (IC50 = 9 ??) and IKACh (IC50=10 ?M) which are only present in atrial myocardium [1].Vernakalant blocks atrial potassium channels, thereby prolonging repolarization. |
Vernakalant Hydrochloride |
A3915-50 |
ApexBio |
50 mg |
EUR 2090.4 |
Description: IC50: Vernakalant inhibits two specific potassium currents, IKur (IC50 = 9 ??) and IKACh (IC50=10 ?M) which are only present in atrial myocardium [1].Vernakalant blocks atrial potassium channels, thereby prolonging repolarization. |
Vilazodone Hydrochloride |
A3919-10 |
ApexBio |
10 mg |
EUR 129.6 |
Description: Vilazodone (EMD 68843; SB 659746A; 5-{4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide hydrochloride) is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression. |
Vilazodone Hydrochloride |
A3919-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Description: Vilazodone (EMD 68843; SB 659746A; 5-{4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide hydrochloride) is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression. |
Vilazodone Hydrochloride |
A3919-50 |
ApexBio |
50 mg |
EUR 157.2 |
Description: Vilazodone (EMD 68843; SB 659746A; 5-{4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide hydrochloride) is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression. |
Voreloxin Hydrochloride |
A3925-10 |
ApexBio |
10 mg |
EUR 895.2 |
Description: Voreloxin is a small molecule and a naphthyridine analogue with antineoplastic activity. Vosaroxin intercalates into DNA in a site-specific manner and blocks the re-ligation process carried out by topoisomerase II during DNA replication. |
Voreloxin Hydrochloride |
A3925-5 |
ApexBio |
5 mg |
EUR 656.4 |
Description: Voreloxin is a small molecule and a naphthyridine analogue with antineoplastic activity. Vosaroxin intercalates into DNA in a site-specific manner and blocks the re-ligation process carried out by topoisomerase II during DNA replication. |
Voreloxin Hydrochloride |
A3925-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 717.6 |
Description: Voreloxin is a small molecule and a naphthyridine analogue with antineoplastic activity. Vosaroxin intercalates into DNA in a site-specific manner and blocks the re-ligation process carried out by topoisomerase II during DNA replication. |